CRL · 10-Q · 2026Q3 · Full report
FX / Currency Impact
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-11-04 · Importance 49 · Surprise 6 · Matches filing data
The company operates globally, with the Euro, Canadian Dollar, and British Pound among the principal functional currencies of its foreign subsidiaries; translation adjustments also reflected the Mauritian Rupee, Chinese Yuan, and Hungarian Forint. It stated that a 10% strengthening of the U.S. dollar, with other variables held constant, would have reduced revenue by $135.8 million and operating income by $33.2 million for the nine months ended September 26, 2026. Management uses financial instruments under its risk-management and hedge policy to limit exposure and does not enter into speculative derivatives.
Key facts
- A 10% strengthening of the U.S. dollar would have reduced nine-month 2026 revenue by $135.8 million and operating income by $33.2 million, all other variables held constant. source
- The Company’s principal foreign-subsidiary functional currencies are the Euro, Canadian Dollar, and British Pound. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | contingent | -2.1% | A 10% strengthening of the U.S. dollar would have reduced nine-month 2026 revenue by $135.8 million and operating income by $33.2 million,… |
| operating_income | negative | contingent | -0.5% | A 10% strengthening of the U.S. dollar would have reduced nine-month 2026 revenue by $135.8 million and operating income by $33.2 million,… |